2 compelling ASX 200 blue chip shares to buy in February

The S&P/ASX 200 Index (ASX: XJO) is home to a good number of shares with true blue chip status.

But given the numerous choices that investors have, it can be hard to decide which ones to include in your portfolio.

In order to narrow things down, I have picked out two blue chip ASX 200 shares which are highly rated right now. They are as follows:

The first ASX 200 blue chip share to consider is CSL. It is one of the world’s leading biotechnology company, responsible for the CSL Behring and Seqirus businesses.

These two businesses are leaders in their respective fields and have a combined portfolio of life-saving and lucrative therapies and vaccines which are generating billions of dollars in sales each year.

But management…